Cancer Therapy with Targeted Radioactive Nanoparticles
Cancer Therapy with Targeted Radioactive Nanoparticles
批准号:
6919627
负责人:
Brian Smith
金额:
$12.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-09 至 2010-05-31
关键词:
adenomatous polypsantibodyantineoplasticsathymic mouseautoradiographydosage formsdrug delivery systemsdrug design /synthesis /productiondrug screening /evaluationelectron microscopyflow cytometrygenetically modified animalsimmunoconjugateslight scatteringnanomedicinenanotechnologyneoplasm /cancer radioimmunotherapynonhuman therapy evaluationpharmacokineticsradiation dosageradionuclidessmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Novel cancer treatments could be realized by marrying radioimmunotherapy (RAIT) with nanotechnology. In this application for a Mentored Quantitative Research Career Development Award (K25), the Candidate proposes to increase the efficacy of RAIT in the setting of malignant solid tumors by packaging radioisotopes in the form of nanoparticles (NPs). This project is a unique collaboration between Candidate Dr. Brian Smith and Mentor Dr. Gregory Adams, who is a respected expert in radioimmunotherapy. The central hypothesis is that immunologically targeted radioactive nanoparticles will prove more therapeutically effective against solid tumors than is typical for RAIT conjugates. This hypothesis will be tested using rhenium radiometal, which has two useful isotopes for RAIT, and single chain Fv (scFv) antibodies which target the tumor-associated HER2/neu antigen. Three sets of experiments are proposed. The first set (Aim 1) focuses on the synthesis of water soluble rhenium NPs. The second set (Aim 2) relates to attachment of scFv molecules to the NPs, and to quantification of the in vitro performance of these nanoparticle radioimmunoconjugates (NPRICs). The results will guide changes to the synthesis parameters in order to produce NPRICs with promising properties for in vivo application. In the third set (Aim 3), the biodistribution and treatment efficacy of optimized NPRICs will be studied in immunodeficient mice with tumor xenografts.
Execution of this project will provide Dr. Smith, who is trained as a materials scientist, with the necessary knowledge and skills to pursue a cross-disciplinary career in the application of nanotechnology to cancer detection and treatment. Specific career goals are (a) education in the areas of nuclear medicine, immunology, and cancer physiology, (b) training in biomedical laboratory practices including immunochemistry and radiochemistry, and (c) training in the proper conduct of animal studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE: Technical Integration (STINGER) and Dissemination (Buzz) Core for COSMIIC HORNET
-
批准号:10549472
-
项目类别:
-
资助金额:$109.46万
-
财政年份:2022
-
负责人:Brian Smith
-
依托单位:
CORE: Technical Integration (STINGER) and Dissemination (Buzz) Core for COSMIIC HORNET
-
批准号:10701825
-
项目类别:
-
资助金额:$127.49万
-
财政年份:2022
-
负责人:Brian Smith
-
依托单位:
SAFETY OF FUROSEMIDE IN PREMATURE INFANTS AT RISK OF BRONCHOPULMONARY DYSPLASIA
-
批准号:8940702
-
项目类别:
-
资助金额:$17.51万
-
财政年份:2014
-
负责人:Brian Smith
-
依托单位:
PATH
-
批准号:8899868
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Brian Smith
-
依托单位:
PATH
-
批准号:8706391
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Brian Smith
-
依托单位:
PATH
-
批准号:8498975
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Brian Smith
-
依托单位:
PATH
-
批准号:8286722
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Brian Smith
-
依托单位:
PATH
-
批准号:8089124
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Brian Smith
-
依托单位:
PATH
-
批准号:7883125
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Brian Smith
-
依托单位:
PATH
-
批准号:7639053
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Brian Smith
-
依托单位:
PATH
-
批准号:7461051
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Brian Smith
-
依托单位:
Cancer Therapy with Targeted Radioactive Nanoparticles
-
批准号:7074607
-
项目类别:
-
资助金额:$12.27万
-
财政年份:2005
-
负责人:Brian Smith
-
依托单位:
国内基金
海外基金
CD8+T细胞亚群在抗MDA5抗体阳性皮肌炎中的致病机制研究
-
批准号:82371805
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:扶琼
-
依托单位:
沙眼衣原体pORF5蛋白功能及其与宿主细胞相互作用的研究
-
批准号:30970165
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2009
-
负责人:李忠玉
-
依托单位: